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Abstract 
Alpha1-adrenoceptor expression on nociceptors may play an important role in sympathetic-sensory 
coupling in certain neuropathic pain syndromes. The aim of this study was to determine whether α1-
adrenoceptor expression was up-regulated on surviving peptidergic, non-peptidergic and myelinated 
nerve fiber populations in the skin after chronic constriction injury of the sciatic nerve in rats. Seven 
days after surgery, α1-adrenoceptor expression was up-regulated in the epidermis and on dermal 
nerve fibres in plantar skin ipsilateral to the injury, but not around blood vessels.  This α1-
adrenoceptor up-regulation in the plantar skin was observed on all nerve fiber populations 
examined. However, α1-adrenoceptor expression was unaltered in dorsal hind paw skin after the 
injury. The increased expression of α1-adrenoceptors on cutaneous nociceptors in plantar skin after 
chronic constriction injury suggests that this may be a site of sensory-sympathetic coupling that 
increases sensitivity to adrenergic agonists after nerve injury. In addition, activation of up-regulated 
α1-adrenoceptors in the epidermis might cause release of factors that stimulate nociceptive 
signalling. 
Perspective:  Our findings indicate that peripheral nerve injury provokes up-regulation of α1-
adrenoceptors on surviving nociceptive afferents and epidermal cells in the skin. This might 
contribute to sympathetically maintained pain in conditions such as complex regional pain 
syndrome, painful diabetic neuropathy and post-herpetic neuralgia. 
Keywords: α1-adrenoceptors; nociceptors; neuropathic pain; chronic constriction injury; 
keratinocytes; sensory-sympathetic coupling 
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Introduction 
Activation of the sympathetic nervous system with consequent release of norepinephrine does not 
normally activate nociceptors. However, after injury, sensory-sympathetic coupling in the skin may 
become a source of pain by activating α1-adrenoceptors (α1-ARs) on nociceptive afferent fibers 
1, 10, 
12, 28, 43
. After nerve injury, messenger RNA for the α1B-AR subtype increases in the dorsal root ganglia 
29, 50
, but whether this results in an up-regulation of α1-ARs on nociceptors in the skin is unknown.  
Chronic constriction injury (CCI) of the rat sciatic nerve triggers signs of pain and hyperalgesia as 
early as 24 hours post-injury 
3, 5, 9, 18
, together with neurodegeneration of sensory nerve fibers in the 
injured sciatic nerve and the skin. The injured nerve fibers regenerate gradually in the weeks 
following injury, resulting in a de novo, spatially intimate association of sprouting sympathetic 
efferent fibers and sensory afferent fibers in the upper dermis 
25-27, 37, 51
. Chemical and surgical 
sympathectomy generally attenuates allodynia and thermal hyperalgesia after CCI 
7, 34
 (but see 
18
), 
suggesting that certain features of the neuropathic pain associated with CCI may be sympathetically 
maintained. Therefore, the aim of this study was to determine whether α1-AR expression was up-
regulated on surviving peptidergic, non-peptidergic and myelinated nerve fiber populations in the 
skin after CCI. As α1-AR expression in the epidermis and on blood vessels could indirectly influence 
nociceptor signalling, α1-AR expression changes on these skin structures were also examined.  
Methods 
Chronic constriction injury 
The experiments conformed to the ethical guidelines of the International Association for the Study 
of Pain, the National Institutes of Health (USA), and the Canadian Institutes of Health Research.  All 
protocols were approved by the Animal Care Committee of the Faculty of Medicine, McGill 
University, in accordance with the regulations of the Canadian Council on Animal Care, and by the 
Animal Ethics Committee of Murdoch University. All animals used in this study were male Sprague 
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Dawley rats weighing 175-200g. Six rats underwent unilateral CCI of the common sciatic nerve 
5
 and 
three rats were examined as naive, un-operated age-matched controls.  
Histological processing and immunohistochemsitry 
Seven days after surgery rats were anesthetised with a lethal dose of sodium pentobarbital (100 
mg/kg, IP) and perfused transcardially with a vascular rinse (0.1M phosphate buffered saline 
containing 0.05% sodium bicarbonate and 0.1% sodium nitrite) followed by freshly prepared 4% 
paraformaldehyde in 0.1M phosphate buffered saline (PBS), pH 7.4.  The hind paws were severed 
and post-fixed overnight, after which a sample of glabrous, plantar skin was excised from the wide 
part of the plantar hind paw that lies distal to the calcaneus and proximal to the digital tori and 
another sample of skin was taken from the dorsum of the hind paw proximal to the toes. The 
samples were cryoprotected in 30% sucrose at 4°C overnight and then embedded in Optimal Cutting 
Temperature compound, frozen on dry ice, and stored at -80°C.  10 µm thick cross-sections were cut 
using a cryostat and collected onto silane coated slides (Hurst Scientific).   
Cryosections were stained with the following combinations of antibodies (details shown in Table 1): 
α1-AR/calcitonin gene related peptide (CGRP)/pan-neuronal marker (TUJ1) to examine α1-AR 
expression on peptidergic afferents; α1-AR/isolectin B4 (IB4)/TUJ1 to examine α1-AR expression on 
non-peptidergic afferents; α1-AR/neurofilament 200 (NF200)/TUJ1 to examine α1-AR expression on 
myelinated fibers; and α1-AR/smooth muscle actin (SMA) to examine α1-AR expression on blood 
vessels.  
For immunohistochemistry, sections initially were washed in 0.1M PBS (3x10 min) and then 
incubated with 0.2% Triton X-100 for 7.5 min at room temperature. Sections were washed with PBS 
(3x5 min) and blocked for 2 hrs in 10% donkey serum in PBS at room temperature. Sections were 
incubated for 48 hrs at 4°C with primary antibodies using the concentrations shown in Table 1, 
diluted in blocking solution. Sections were washed with PBS (3x15 min) and then incubated with the 
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appropriate secondary antibodies diluted in 5% donkey serum (Sigma) in PBS for 4 hrs at room 
temperature. Sections were washed with PBS (3x15 min) and cover-slipped with Prolong Gold anti-
fade mounting media.  
The peptide sequence recognized by the α1-AR antibody used in this study is unique to the α1-AR, a 
G-protein-coupled receptor (National Center for Biotechnology Information, National Institutes of 
Health, BLAST program, http://blast.ncbi.nlm.nih.gov/Blast.cgi). In an examination of the specificity 
of the α1-AR antibody, the pattern of staining on blood vessels, nerves and epidermal cells in rat skin 
tissue resembled the staining pattern produced by BODIPY FL-prazosin, a fluorescent α1-AR 
antagonist. 
6
 In addition, staining was eliminated following pre-adsorption of the anti-sera with an 
α1-AR-specific peptide. 
6
  In the present study, no staining was observed on negative control sections 
that had the primary antibodies omitted. Two consecutive sections per sample were stained with a 
combination of antibodies, and immunohistochemistry for each antibody combination was 
performed in one run to ensure staining consistency.   
Quantification of Immunohistochemistry 
α1-AR staining intensity was quantified in the epidermis, dermal blood vessels, nerve fibers in the 
upper dermis, and nerve fibers in large dermal nerve bundles by a blinded investigator. The 
epidermis was identified by morphology, blood vessels were identified by SMA staining and nerve 
fibers in the dermis and nerve bundles were identified using the pan-neuronal marker TUJ1. α1-AR 
staining intensity in the epidermis and nerve fibers was quantified in 7 sections per sample and 
averaged. Since many blood vessels were present in each skin section, α1-AR staining intensity in 
small blood vessels in the papillary dermis proximal to the epidermis was quantified as the average 
intensity in the smooth muscle surrounding all blood vessels in two representative images taken 
from one section per sample. One additional image from each α1-AR/SMA stained section was 
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collected from the deeper reticular dermis and used to quantify α1-AR staining intensity in the 
smooth muscle surrounding large blood vessels.  
Images of immunostained skin sections were collected using a Nikon A1 confocal microscope. For 
quantification of α1-AR intensity, two 200X magnification confocal image stacks were collected per 
section; one image stack contained the papillary dermis, epidermis and dermal nerve fibers, and the 
other image stack was of the large dermal nerve bundles in the reticular dermis. Two 200X images of 
the papillary dermis and one from the reticular dermis were collected from sections stained with α1-
AR and SMA for quantification of α1-AR expression on blood vessels. All confocal stacks consisted of 
consecutive images collected with an optical section thickness of 2 µm, and the maximum intensity 
projection overlay of the resulting stack was used for quantification. Special care was taken to 
ensure that there was no bleed-through between channels using the imaging settings chosen, and 
imaging settings were identical for all sections in each staining run.  
Quantification of immunohistochemistry staining intensity was performed using ImageJ software 
(available from http://rsbweb.nih.gov.ij).  The proportion of each nerve bundle occupied by nerve 
fibers was calculated in 4-7 nerve bundles per sample. Nerve bundles were identified using a 
combination of morphology and TUJ1 staining. The perimeter of each nerve bundle was manually 
traced around and the area was measured. An intensity threshold was applied to all TUJ1 images, 
which ensured that only immuno-positive TUJ1 (TUJ1
+
) pixels were included in analysis, and the 
proportion of TUJ1
+
 pixels in each nerve bundle was determined.  
α1-AR staining intensity was measured as the average pixel intensity in each area of interest.TUJ1 
staining was used to identify the location of nerve fibers, which was then used as a mask on the 
corresponding α1-AR stained image, ensuring that α1-AR expression was only examined in those 
pixels also positive for TUJ1 staining. Similarly, quantification of the average α1-AR intensity on blood 
vessels was performed by creating a mask from SMA immunostaining and using that to define the 
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location of blood vessels in the corresponding α1-AR image. Quantification of α1-ARs in the epidermis 
was performed by manually drawing around the keratinocyte layer and measuring the average α1-AR 
intensity in the defined region.  
α1-AR staining intensity was also examined in specific primary afferent neuron subpopulations: 
peptidergic CGRP
+
 neurons, non-peptidergic IB4
+
 neurons and myelinated NF200
+
 neurons.  For this 
quantification, a co-localisation analysis was performed between each of these specific neuronal 
markers and TUJ1 using the “Co-localization Finder” plugin to create a mask of pixels that identified 
each individual neuronal population. This mask was applied to the corresponding α1-AR image and 
α1-AR staining intensity was then quantified in these specific neuronal populations. The proportion 
of nerve fibers belonging to each of these populations was quantified by expressing the number of 
pixels co-localized for TUJ1 and CGRP, IB4 or NF200 as a percentage of the total number of pixels 
labelled for TUJ1.  
Statistical approach  
To combine data for neural markers across multiple immunohistochemistry runs, α1-AR
+
 pixel 
intensity within each run was expressed as a Z-score for each region of interest (nerve fibers in the 
papillary dermis and nerve bundles in the reticular dermis). Mean scores were then compared 
between the injured and contralateral limb with Wilcoxon’s Signed Ranks test, and between 
experimental and control animals with the Mann-Whitney U test. A similar approach was used to 
investigate differences in α1-AR
+
 pixel intensity in the epidermis and blood vessel walls, and in 
peptidergic, non-peptidergic and myelinated neuron populations throughout the papillary and 
reticular dermis. Results are reported as the mean ± standard error, and the criterion of statistical 
significance was p<0.05.  
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Results 
Neurodegeneration after CCI 
The proportion of pixels within nerve bundles labelled by the pan-neuronal marker TUJ1 was used to 
index the extent of neurodegeneration. There was a trend for this index to be lower in skin 
ipsilateral than contralateral to CCI and in comparison to skin from naive animals both in plantar and 
hairy skin (Table 2), but this trend did not achieve statistical significance.  
The surviving dermal TUJ1
+
 fibers were then separated into peptidergic, non-peptidergic and 
myelinated neuron populations, and the proportions of these populations were compared across 
experimental groups to determine whether any of these populations were particularly vulnerable to 
CCI. There was a profound degeneration of NF200
+
 fibers in plantar skin ipsilateral to CCI (Figure 1); 
the percentage of NF200
+
 pixels co-labelled for TUJ1 decreased to 6±2% of the total number of TUJ1
+
 
pixels, which was lower than in skin contralateral to CCI (24±5%, p<0.05) and in naive animals (28± 
6%, p<0.05). This degeneration was specific to NF200
+
 fibers as the proportions of CGRP
+
 and IB4
+
 
pixels remained unchanged after CCI (Table 3). Interestingly, the degeneration of myelinated fibers 
was observed in plantar skin but not in hairy skin on the dorsal paw (Figure 1 and Table 3).  
α1-AR expression in skin of naïve rats 
The strongest α1-AR expression was observed in the epidermis. α1-AR expression was also observed 
around blood vessels and in nerve fibers in the dermis and in large dermal nerve bundles. The strong 
α1-AR expression throughout the epidermis precluded observation of α1-ARs on intra-epidermal 
nerve fibers. The pattern of α1-AR staining was consistent with a previous study that examined α1-AR 
staining in skin from uninjured rats 
6
.  
α1-AR up-regulation in plantar skin after nerve injury  
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α1-AR expression was up-regulated after CCI in all regions examined in ipsilateral plantar skin except 
around blood vessels.  CCI resulted in significantly increased α1-AR expression on nerve fibers 
labelled with TUJ1 (TUJ1
+
) and in nerve bundles in the deep dermis in comparison to skin 
contralateral to CCI (p<0.05) and to skin from naive animals (p<0.05) (Figure 2, Figure 3A). α1-AR 
expression was also significantly higher in TUJ1
+
 nerve fibers in the papillary dermis in skin ipsilateral 
to CCI than in contralateral skin (p<0.05) (Figure 3B).  
α1-AR expression was then examined in individual primary afferent subpopulations. In those nerve 
fibers that remained after injury, α1-AR expression was significantly higher on CGRP
+
 fibers in skin 
ipsilateral than contralateral to CCI (p<0.05) (Figure 4A).  α1-AR expression was also significantly 
higher in IB4
+ 
fibers in skin ipsilateral than contralateral to CCI (p<0.05) and in comparison to skin 
from naive animals (p<0.05) (Figure 4B). Similarly, in the few remaining plantar dermal NF200
+
 
fibers, α1-AR expression was higher ipsilateral than contralateral to CCI (p<0.05) (Figure 4C). 
α1-AR expression was significantly higher in the epidermis ipsilateral than contralateral to CCI 
(p<0.05) and in comparison to skin from naive animals (p<0.01) (Figure 3C, Figure 5). There was no 
difference in α1-AR expression in the epidermis from skin contralateral to CCI compared to skin from 
naive animals. There were also no significant differences in the average α1-AR staining intensity in 
small blood vessels in the papillary dermis or large blood vessels in the reticular dermis after CCI in 
comparison to skin contralateral to CCI or to skin from naive animals (Figure 6A).  
α1-AR expression in hairy skin 
α1-AR expression was not altered in the epidermis, dermal blood vessels, nerve fibers in the dermis 
or nerve fibers in dermal nerve bundles in hairy skin after CCI in comparison either to skin from the 
contralateral paw or from naive rats (Figure 3D-F and Figure 6B). As immunohistochemistry of hairy 
skin was performed at the same time as plantar skin, and α1-AR staining intensity was consistent 
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between groups in all structures examined in hairy skin, these results suggest that α1-AR expression 
was not up-regulated in hairy skin at 7 days post-CCI.    
Discussion 
α1-AR expression was increased on cutaneous nerve fibers and in the epidermis after CCI. We have 
previously shown that nociceptors express α1-ARs basally 
6
. Others have shown that surviving nerve 
fibers become more sensitive to α1-AR agonists after nerve injury 
2, 33
 and that administration of α1-
AR antagonists reduces thermal and mechanical hyperalgesia in animal models of neuropathic pain 
14, 19, 20, 22, 49
. The increased expression of α1-ARs on cutaneous nociceptors after CCI suggests that this 
may be a site of sensory-sympathetic coupling, and could provide a mechanism underlying this 
hypersensitivity to adrenergic agonists after nerve injury. It has been hypothesised that direct 
activation of α1-ARs on non-peptidergic nociceptors expressing the P2X3 receptor enhances the 
firing rate to painful stimuli by activating protein kinase C 
29, 31
. Considering that we also found α1-AR 
up-regulation on non-peptidergic nociceptors after CCI, this could provide a potential direct link 
between increased α1-AR expression on nociceptors and neuropathic pain.  
α1-AR expression was up-regulated on nerve fibers co-labelled with CGRP
+
 or IB4
+
, and was also up-
regulated in nerve bundles on fibers co-labelled with NF200, a marker of myelinated nociceptive and 
non-nociceptive neurons. These nerve fibers may carry different types of pain information; CGRP
+
 
nociceptors respond to noxious heat and are partly responsible for hypersensitivity to heat after 
nerve injury 
17, 30
, whereas non-peptidergic nociceptors respond both to noxious heat and 
mechanical stimuli and contribute to heat hypersensitivity and mechanical allodynia after nerve 
injury 
16, 41, 42, 45, 46
. Similarly, decreases in the firing threshold of myelinated nociceptors may increase 
the intensity of sharp, pricking pain after nerve injury 
8
. Therefore, if α1-AR expression increases the 
excitability of these nociceptors, α1-AR up-regulation could potentially contribute to symptoms of 
neuropathic pain.  
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α1-AR expression may also influence pain signalling indirectly by stimulating the release of secondary 
mediators that act on nociceptors. α1-AR expression was increased throughout the epidermis in 
plantar skin affected by CCI. The normal epidermis contains nerve fibers, Langerhans cells, 
melanocytes, and keratinocytes.  Melanocytes and Langerhans cells are relatively rare and are 
confined almost exclusively to the basal (germinative) layer, whereas keratinocytes are present in all 
the vital layers. Keratinocytes can influence nerve signalling by releasing various factors that are 
capable of activating and sensitizing nerve fibers after injury including nerve growth factor (NGF), 
pro-inflammatory cytokines, CGRP and ATP 
15, 23, 24, 38, 40, 53
. Given the up-regulation of α1-AR 
expression in the CCI-affected plantar epidermis, it could be hypothesised that activation of these 
receptors might cause release of factors from keratinocytes and/or other epidermal cells that are 
capable of stimulating nociceptive signalling, resulting in sensitization of these nociceptive nerve 
fibers and contributing to neuropathic pain. The release of NGF could be of particular importance as 
it might not only sensitize nociceptive afferents but could also promote the growth of re-innervating 
cutaneous sympathetic nerve fibers into the upper dermis after CCI; these fibers grow in close 
proximity to nociceptors and are a possible source of the norepinephrine needed to activate α1-ARs 
51
. Keratinocytes and melanocytes also have the capacity to synthesize catecholamines 
13
. Thus, one 
could speculate that autocrine stimulation of α1- or β2-ARs
23
 on these epidermal cells triggers a 
cascade of inflammatory mediators that augment neuropathic pain.  
α1-AR up-regulation was observed in plantar skin but not in hairy skin on the dorsal paw. This was an 
unexpected finding as both types of skin are innervated by branches of the sciatic nerve, and TUJ1 
staining suggested a trend for neurodegeneration in both regions. Interestingly, in a previous study, 
neurons in hairy skin regenerated faster than neurons in plantar skin after sciatic nerve injury 
39
, 
suggesting that there may be some inherent difference between these regions that results in 
different responses to injury. Our finding that NF200
+
 fibers were profoundly degenerated in plantar, 
but not hairy, skin supports this hypothesis. Extensive degeneration of myelinated fibers after CCI 
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has been observed previously 
4, 32, 37
. However, this is the first study to compare the degeneration in 
plantar and hairy skin. Why there was a difference between the two types of skin in the response to 
nerve injury is not yet understood, but one major difference is that the plantar skin is completely 
innervated by branches of the sciatic nerve whereas the medial section of the dorsal hind paw is 
innervated by the saphenous nerve 
47
. One could speculate that the presence of uninjured 
saphenous nerve fibers in the hairy skin could provide a neuroprotective effect, at least during the 
first week after injury (the only time point examined in this study). In addition, it would be 
interesting to determine whether a functional process (e.g., triggered by weight-bearing on the 
plantar surface of the paw
11
) influenced the response to CCI. 
α1-AR expression on large and small blood vessels was unaffected by CCI. This is interesting as blood 
vessels appear to have heightened sensitivity to α1-AR agonists after injury 
21, 49, 52
. This has resulted 
in the hypothesis that  α1-AR expression may be increased on blood vessels in cases of 
sympathetically-maintained pain and that α1-AR activation causes pain by inducing vasoconstriction 
48
. Our results suggest that increased vascular sensitivity to α1-AR agonists after injury is not due to 
increased vascular expression of α1-ARs, at least in the CCI model, but instead may be a direct 
consequence of denervation of blood vessels and consequent loss of neuronal norepinephrine 
transporters 
44
. This could explain both the lack of α1-AR up-regulation on blood vessels and 
increased sensitivity to α1-AR agonists observed after CCI.  
One limitation of this study was that α1-AR expression was examined at only one time point, 7 days 
post-injury. This time point was chosen because previous studies have consistently reported the 
presence of mechanical and thermal hyperalgesia at this early post-injury time 
5, 18, 35, 36
. However, it 
would be interesting in future studies to determine whether α1-AR up-regulation is present at later 
time points. In addition, it would be useful to include sham operated animals in future studies to 
investigate possible nonspecific effects of surgery. 
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In conclusion, the up-regulation of α1-ARs both in the epidermis and on nerve fibers in skin affected 
by CCI provides insights into the mechanism of involvement of the sympathetic nervous system in 
neuropathic pain. The increased expression of α1-ARs after injury suggests that epidermal cells and 
nociceptive nerve fibers may become more sensitive to epinephrine and norepinephrine released as 
a result of sympathetic neural or adrenal gland excitation, or perhaps even synthesized locally within 
the epidermis. This could either directly activate α1-ARs expressed on nociceptors or indirectly excite 
nociceptors by activation of epidermal cells and consequent release of factors that act on 
nociceptive nerve fibers.  
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Figure Legends 
Figure 1. Representative images of NF200
+
 fibers in nerve bundles in the reticular dermis of plantar 
and hairy skin. Dashed lines identify the perimeter of nerve bundles. Scale bar = 50 µm 
Figure 2. Representative images of α1-AR expression in nerve bundles in the reticular dermis of 
plantar skin. α1-AR expression was increased in nerve bundles in skin affected by CCI (lesioned) in 
comparison to skin on the contralateral limb to CCI (contra) and from naive animals. α1-AR 
immunoreactivity co-localised with the pan-neuronal marker TUJ1. Co-localized pixels are shown in 
white in the co-localized panel of images. Scale bar = 50 µm  
Figure 3. α1-AR immunoreactivity (expressed as Z-scores ± S.E.) in dermal TUJ
+
 nerve fibers and on 
epidermal cells on the injured and contralateral sides after chronic constriction injury (N = 6) and in 
naïve animals (N = 3). A-C: In plantar skin, α1-AR immunoreactivity was greater on the injured than 
contralateral side in nerve fibers and on epidermal cells (* p<0.05), and was greater on the injured 
side than in uninjured naïve animals (#p<0.05). D-F: In the dorsal paw, α1-AR immunoreactivity was 
similar in injured and naïve animals.  
Figure 4. α1-AR immunoreactivity (expressed as Z-scores ± S.E.) in TUJ
+
 nerve fibers in plantar skin 
co-labelled with CGRP, IB4 or NF200 after chronic constriction injury (N = 6) and in naïve animals (N 
= 3). A: α1-AR expression on fibers co-labelled with CGRP was greater on the injured than 
contralateral side (* p<0.05). B:  α1-AR expression on fibers co-labelled with IB4 was greater on the 
injured than contralateral side (* p<0.05), and was greater on the injured side than in uninjured 
naïve animals (#p<0.05). C: Trends were similar in nerve fibers co-labelled with NF200. 
Figure 5. Representative images of α1-AR expression in the epidermis. α1-AR immunoreactivity was 
increased after CCI in plantar skin, but not hairy skin in the dorsal hind paw, in comparison to skin 
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contralateral to CCI and from naive animals. HF: indicates location of hair follicles in hairy skin. Scale 
bar = 100 µm 
Figure 6. Representative image of α1-AR expression in a dermal blood vessel stained with smooth 
muscle actin (SMA) (scale bar = 40 µm). α1-AR immunoreactivity (expressed as Z-scores ± S.E.) on 
cells co-labelled with SMA was similar on the injured and contralateral sides after chronic 
constriction injury (N = 6) and in naïve animals (N = 3) both (A) in plantar and (B) hairy skin. 
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Table 1: Primary and secondary antibodies 
Antibody  Dilution Product code and Source 
anti α1-AR, rabbit polyclonal 1:200 A270, Sigma-Aldrich 
anti BIII-tubulin (TUJ1), mouse monoclonal 1:800 MMS-435P, Covance 
anti CGRP, goat polyclonal 1:400 1720-9007, AbD Serotec 
IB4, FITC conjugate 1:250 L2895, Sigma-Aldrich 
anti NF200, chicken polyclonal 1:4000 Jackson ImmunoResearch 
anti-SMA, mouse monoclonal 1:4000 A2547, Sigma-Aldrich 
anti-chicken Cy2 1:600 Jackson ImmunoResearch 
anti-goat 488 1:600 Jackson ImmunoResearch 
anti-rabbit 549 1:1200 Jackson ImmunoResearch 
anti-mouse 647 1:1000 Jackson ImmunoResearch 
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Table 2: Proportion of TUJ1
+
 pixels within nerve bundles after CCI 
 Mean ± S.E. (% of total area) 
  Naïve 
(N = 3) 
CCI ipsilateral 
(N = 6) 
CCI contralateral 
(N = 6) 
Plantar skin 21±4 11±3 17±5 
Dorsal skin 32±6 17±3 30±6 
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Table 3: Neural markers expressed as a proportion of dermal TUJ1
+
 pixels  
 Mean ± S.E. (% of TUJ1
+
 pixels) 
  Naïve 
(N = 3) 
CCI ipsilateral 
(N = 6) 
CCI contralateral 
(N = 6) 
Plantar skin    
   CGRP 35±6 37±8 40±5 
   IB4 35±1 34±5 37±7 
   NF200 28±6    6±2 * 24±5 
Dorsal skin    
   CGRP 38±19 45±13 40±8 
   IB4 38±5 36±8 51±11 
   NF200 23±3 23±5 24±5 
* p<0.05 compared with CCI contralateral and naïve animals 
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